NCT07039136 Virtual Reality Mirrors Therapy Usability
| NCT ID | NCT07039136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 172 participants |
| Start Date | 2025-06-28 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 172 participants in total. It began in 2025-06-28 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mirror therapy has been shown to support motor recovery by stimulating neural mechanisms through visual feedback. Recent technological advancements, particularly in virtual reality (VR), have enabled the development of more immersive and interactive rehabilitation tools. This study focuses on evaluating the usability of a novel, Leap Motion-based Virtual Reality Mirror Therapy (VRMT) system designed to enhance upper limb rehabilitation in stroke patients by combining traditional mirror therapy principles with engaging, gamified digital environments.
Eligibility Criteria
Inclusion Criteria: * Stereo acuity score of 3552 arc/sec in the Titmus Fly Test * No prior virtual reality experience Exclusion Criteria: * Severe sensory impairments (vision or hearing) * Being diagnosed with neurological disorders
Contact & Investigator
ramazan kurul, Ph.D
PRINCIPAL INVESTIGATOR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT07039136 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07039136 currently recruiting?
Yes, NCT07039136 is actively recruiting participants. Contact the research team at omerosman.pala@ibu.edu.tr for enrollment information.
Where is the NCT07039136 trial being conducted?
This trial is being conducted at Bolu, Turkey (Türkiye), Bolu, Turkey (Türkiye).
Who is sponsoring the NCT07039136 clinical trial?
NCT07039136 is sponsored by Abant Izzet Baysal University. The principal investigator is ramazan kurul, Ph.D at Abant Izzet Baysal University. The trial plans to enroll 172 participants.